Start Date and Time
April 29, 2013 2:00 PM
End date and time
May 1, 2013 12:30 PM
(GMT-06:00) Central Time (US & Canada)
One Deloitte Way
Amy Mersinger Registration options
Event registration is closed.
8th Annual Deloitte Life Sciences Tax Conference is scheduled for April 29-May 1, 2013 at Deloitte University. This two day educational program is designed for pharmaceutical, biotechnology and medical device companies. This conference allows participants to enhance their technical skillset to help them succeed in today's demanding life sciences tax environment. Participants will hear from both Deloitte life sciences specialists as well as industry tax leaders from peer companies. Combining specific technical topics with the latest leading tax practices focused on the life sciences industry makes this the must attend tax event for 2013.
Download the agenda
here. Check back for updates. Conference highlights
Understand the outlook for comprehensive tax reform and its impact to the industry, including IP planning, inbound and outbound international tax provisions, and the tradeoffs which may be necessary to address corporate tax burdens.
Discover what is "hot" in the industry and affecting life sciences today, where the industry is headed tomorrow, and how these industry trends impact life sciences tax practitioners
Participate in content-rich technical workshops focused specifically on life sciences tax issues, including international tax, transfer pricing, multistate tax, IRS Controversy, and regulatory developments, including the Medical Device Excise Tax and the Branded Prescription Drug Fee
SPECIAL pre-event "Life Sciences M&A Workshop" - learn about specific issues that are important on both the buy and sell side of an M&A transaction. Kicking off with the deal itself, presenters will focus on approach, purchase agreements, due diligence and transaction forms. This deep dive will then touch on purchase price allocations, current accounting standards and fair value issues in the industry. Lastly, we will explore post-merger integration pitfalls and leading practices.
Who should attend?
Tax professionals at pharmaceutical, biotech, and medical device companies, as well as service companies, which include distributors of drugs and devices, contract research organizations (CROs) and contract manufacturing organizations (CMOs)
Accounting/Finance/Legal professionals at Life Sciences companies who have responsibilities connected to the tax arena.
PLEASE NOTE: Attendance is limited to life sciences industry professionals.
This conference may qualify you for up to 15.5 Tax and 1.5 Specialized Knowledge Application CPE credits.
Deloitte LLP believes that its public audit clients should obtain audit committee pre-approval for tax seminar enrollments. If your company is audited by Deloitte LLP, you may enroll in this seminar if you have already obtained, or will obtain such approval.
Event registration is closed.